•
VC
VCYT
Veracyte, Inc.
yahooSERVICES-MEDICAL LABORATORIES
--
Price Chart
Market Cap
3.42B
Volume
535.89K
52W High
$50.71
52W Low
$22.61
Open
$0.00
Prev Close
$41.69
Day Range
0.00 - 0.00
About Veracyte, Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
Latest News
Healthcare Innovation Accelerates as Four Converging Forces Drive Early Intervention Focus
Benzinga•Sep 25
Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide
GlobeNewswire Inc.•Apr 8
Diagnostic Company Veracyte Weighs Sale For French Subsidiary, Analyst Says 'Walking Away' Is A Long-Term Positive
Benzinga•Feb 25
Should You Continue to Retain PODD Stock in Your Portfolio Now?
Benzinga•Sep 4
Globus Medical (GMED) Global Sales, Innovation Aid Growth - Zacks Investment Research
Zacks Investment Research•Jul 19
Insider Sale: Director Jens Holstein Sells 5,000 Shares of Veracyte Inc (VCYT) By GuruFocus - Investing.com Canada
Investing.com•Jul 19
3 Medical Instruments Picks to Navigate Industry Challenges
Zacks Investment Research•Jun 28
Zacks.com featured highlights Veracyte, Steelcase and Applied Industrial
Zacks Investment Research•Jun 26